Daniel H. O’Donovan

1.4k total citations · 1 hit paper
27 papers, 833 citations indexed

About

Daniel H. O’Donovan is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Daniel H. O’Donovan has authored 27 papers receiving a total of 833 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Organic Chemistry and 3 papers in Oncology. Recurrent topics in Daniel H. O’Donovan's work include Chemical Synthesis and Analysis (7 papers), Epigenetics and DNA Methylation (4 papers) and Catalytic C–H Functionalization Methods (3 papers). Daniel H. O’Donovan is often cited by papers focused on Chemical Synthesis and Analysis (7 papers), Epigenetics and DNA Methylation (4 papers) and Catalytic C–H Functionalization Methods (3 papers). Daniel H. O’Donovan collaborates with scholars based in United Kingdom, United States and Ireland. Daniel H. O’Donovan's co-authors include David R. Spring, Jessica Iegre, Isabel Rozas, Daniel B. Menzel, Claudia De Fusco, Nuno Maulide, Andreas Reichel, Lara Kuhnke, Fernando Blanco and Igor D. Jurberg and has published in prestigious journals such as Chemical Society Reviews, Angewandte Chemie International Edition and International Journal of Molecular Sciences.

In The Last Decade

Daniel H. O’Donovan

27 papers receiving 814 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Peptides as a platform for targeted therapeutics for cancer: peptide–drug conjugates (PDCs)

2020 293 citations Jessica Iegre, Daniel H. O’Donovan et al. Chemical Society Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel H. O’Donovan United Kingdom	16	451	301	138	69	55	27	833
John C. Widen United States	12	439 1.0×	318 1.1×	93 0.7×	26 0.4×	102 1.9×	16	863
Keizo Koya United States	19	627 1.4×	406 1.3×	205 1.5×	33 0.5×	47 0.9×	31	1.2k
Gunnar J. Hanson United States	18	556 1.2×	339 1.1×	56 0.4×	33 0.5×	42 0.8×	37	834
Sofia Nascimento dos Santos Brazil	13	311 0.7×	506 1.7×	98 0.7×	63 0.9×	76 1.4×	39	969
Natasha S. Murphy United Kingdom	8	653 1.4×	379 1.3×	91 0.7×	72 1.0×	35 0.6×	10	850
Nichola L. Davies United Kingdom	11	494 1.1×	261 0.9×	91 0.7×	54 0.8×	22 0.4×	15	683
Yujia Wang China	11	619 1.4×	413 1.4×	91 0.7×	52 0.8×	19 0.3×	14	827
Eva Altmann Switzerland	18	691 1.5×	494 1.6×	147 1.1×	38 0.6×	21 0.4×	39	1.1k
Jean‐Louis Kraus France	18	407 0.9×	453 1.5×	87 0.6×	31 0.4×	19 0.3×	73	996
Sylvain Broussy France	16	424 0.9×	218 0.7×	75 0.5×	29 0.4×	52 0.9×	37	724

Countries citing papers authored by Daniel H. O’Donovan

Since Specialization

Citations

This map shows the geographic impact of Daniel H. O’Donovan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel H. O’Donovan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel H. O’Donovan more than expected).

Fields of papers citing papers by Daniel H. O’Donovan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel H. O’Donovan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel H. O’Donovan. The network helps show where Daniel H. O’Donovan may publish in the future.

Co-authorship network of co-authors of Daniel H. O’Donovan

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel H. O’Donovan. A scholar is included among the top collaborators of Daniel H. O’Donovan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel H. O’Donovan. Daniel H. O’Donovan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Carlino, Luca, Peter C. Astles, Afshan Ahmed, et al.. (2024). Identification of Novel Potent NSD2-PWWP1 Ligands Using Structure-Based Design and Computational Approaches. Journal of Medicinal Chemistry. 67(11). 8962–8987. 7 indexed citations

O’Donovan, Daniel H., et al.. (2023). Addressing the Reciprocal Crosstalk between the AR and the PI3K/AKT/mTOR Signaling Pathways for Prostate Cancer Treatment. International Journal of Molecular Sciences. 24(3). 2289–2289. 32 indexed citations

O’Donovan, Daniel H., David Baker, Giovanni Ciotta, et al.. (2023). Discovery and characterisation of quinazolines and 8-Azaquinazolines as NLRP3 agonists with oral bioavailability in mice. Bioorganic & Medicinal Chemistry Letters. 96. 129518–129518. 1 indexed citations

O’Donovan, Daniel H., Martin J. Packer, Ryan Greenwood, et al.. (2021). Free energy perturbation in the design of EED ligands as inhibitors of polycomb repressive complex 2 (PRC2) methyltransferase. Bioorganic & Medicinal Chemistry Letters. 39. 127904–127904. 11 indexed citations

Holdgate, Geoffrey A., Catherine Bardelle, Jon Read, et al.. (2021). Drug discovery for epigenetics targets. Drug Discovery Today. 27(4). 1088–1098. 22 indexed citations

Iegre, Jessica, et al.. (2020). Peptides as a platform for targeted therapeutics for cancer: peptide–drug conjugates (PDCs). Chemical Society Reviews. 50(3). 1480–1494. 293 indexed citations breakdown →

O’Donovan, Daniel H., et al.. (2020). Targeting PRC2 for the treatment of cancer: an updated patent review (2016 - 2020). Expert Opinion on Therapeutic Patents. 31(2). 119–135. 35 indexed citations

Iegre, Jessica, P. Brear, David Baker, et al.. (2019). Efficient development of stable and highly functionalised peptides targeting the CK2α/CK2β protein–protein interaction. Chemical Science. 10(19). 5056–5063. 30 indexed citations

Read, Jon, Jonathan Tart, Philip B. Rawlins, et al.. (2019). Rapid Identification of Novel Allosteric PRC2 Inhibitors. ACS Chemical Biology. 14(10). 2134–2140. 9 indexed citations

10.

Iegre, Jessica, Josephine Gaynord, Yuteng Wu, et al.. (2018). Stapled peptides as a new technology to investigate protein–protein interactions in human platelets. Chemical Science. 9(20). 4638–4643. 27 indexed citations

11.

O’Donovan, Daniel H., Paul Aillard, Martin Berger, et al.. (2018). C−H Activation Enables a Concise Total Synthesis of Quinine and Analogues with Enhanced Antimalarial Activity. Angewandte Chemie International Edition. 57(33). 10737–10741. 49 indexed citations

12.

O’Donovan, Daniel H., Paul Aillard, Martin Berger, et al.. (2018). C‐H‐Aktivierung ermöglicht eine kurze Totalsynthese von Chinin und Analoga mit erhöhter Anti‐Malaria‐Aktivität. Angewandte Chemie. 130(33). 10897–10901. 7 indexed citations

13.

O’Donovan, Daniel H., Claudia De Fusco, & David R. Spring. (2016). The reductive cleavage of picolinic amides. Tetrahedron Letters. 57(27-28). 2962–2964. 36 indexed citations

14.

O’Donovan, Daniel H., Carolina Muguruza, Luís F. Callado, & Isabel Rozas. (2014). Guanidine-based α2-adrenoceptor ligands: Towards selective antagonist activity. European Journal of Medicinal Chemistry. 82. 242–254. 8 indexed citations

15.

Peng, Bo, Daniel H. O’Donovan, Igor D. Jurberg, & Nuno Maulide. (2012). Dual Nucleophilic/Electrophilic Capture of In Situ Generated Iminium Ethers: Towards the Synthesis of Functionalized Amide Building Blocks. Chemistry - A European Journal. 18(51). 16292–16296. 31 indexed citations

16.

O’Donovan, Daniel H. & Isabel Rozas. (2012). New methods for the preparation of aryl 2-iminoimidazolidines. Tetrahedron Letters. 53(34). 4532–4535. 16 indexed citations

17.

Kelly, Brendan, Daniel H. O’Donovan, John E. O’Brien, et al.. (2011). Pyridin-2-yl Guanidine Derivatives: Conformational Control Induced by Intramolecular Hydrogen-Bonding Interactions. The Journal of Organic Chemistry. 76(22). 9216–9227. 21 indexed citations

18.

O’Donovan, Daniel H. & Isabel Rozas. (2011). A concise synthesis of asymmetrical N,N′-disubstituted guanidines. Tetrahedron Letters. 52(32). 4117–4119. 15 indexed citations

19.

Quinn, Susan J., John M. Kelly, Daniel H. O’Donovan, et al.. (2010). Understanding the DNA binding of novel non-symmetrical guanidinium/2-aminoimidazolinium derivatives. Organic & Biomolecular Chemistry. 8(24). 5558–5558. 34 indexed citations

20.

O’Donovan, Daniel H. & Daniel B. Menzel. (1978). Mechanisms of lipid peroxidation: Iron catalyzed decomposition of fatty acid hydroperoxides as the basis of hydrocarbon evolution in vivo. Cellular and Molecular Life Sciences. 34(6). 775–776. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact